Zhejiang Cheng Yi Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is AZATHIOPRINE, with a corresponding US DMF Number 26847.
Remarkably, this DMF maintains an Active status since its submission on December 15, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 28, 2016, and payment made on November 14, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II